Journal Article Summary
The article investigates new aspirin derivatives that release nitroxyl (HNO) and nitric oxide (NO) to improve the safety and efficacy of non-steroidal anti-inflammatory drugs (NSAIDs). Traditional NSAIDs, while effective for pain and inflammation, can cause serious side effects like gastrointestinal ulcers and increased risk of heart attacks. The study aims to develop and compare these new compounds to assess their potential benefits in reducing side effects while maintaining therapeutic effects.
The researchers synthesized two new aspirin derivatives, IPA/NO-aspirin and DEA/NO-aspirin, and evaluated their chemical properties and biological effects. They found that both compounds showed enhanced cytotoxicity against non-small cell lung cancer cells while being less toxic to normal endothelial cells. Additionally, these new derivatives demonstrated anti-inflammatory properties and improved heart muscle contractility, suggesting their potential use in treating inflammation, cancer, and heart failure.
However, the study has limitations, including the need for further research to fully understand the long-term effects and safety of these new compounds in humans. Patients should consult healthcare professionals before considering any new treatments, especially those involving modified NSAIDs, to discuss potential risks and benefits. It is essential to ensure that any new medication aligns with individual health needs and conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Basudhar Debashree, Bharadwaj Gaurav, Cheng Robert Y., Jain Sarthak, Shi Sa, Heinecke Julie L., Holland Ryan J., Ridnour Lisa A., et al.. Synthesis and Chemical and Biological Comparison of Nitroxyl and Nitric Oxide Releasing Diazeniumdiolate-based Aspirin Derivatives. Journal of medicinal chemistry 2013. DOI: 10.1021/jm400196q. PMID: 24102516. PMCID: PMC3880621.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
